Sylvie Glaisner
- Pathology and Forensic Medicine top 10%
- Genetics top 10%
- Neurology top 10%
- Oncology
- Immunology
- Co-authors
- Hervé DombretL DegosSylvie CastaignéFranck MorschhauserRichard DelarueCorinne HaïounJean GabarreJu Li
- Topics
- Lymphoma Diagnosis and Treatment (6 papers)CNS Lymphoma Diagnosis and Treatment (4 papers)Glioma Diagnosis and Treatment (3 papers)
- Partner nations
- FranceAustraliaUnited States
In The Last Decade
Sylvie Glaisner
16 papers receiving 327 citations
Peers
Comparison fields: 5 of 47
- Pathology and Forensic Medicine 188
- Genetics 124
- Neurology 118
- Oncology 100
- Immunology 73
Countries citing papers authored by Sylvie Glaisner
This map shows the geographic impact of Sylvie Glaisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Glaisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Glaisner more than expected).
Fields of papers citing papers by Sylvie Glaisner
This network shows the impact of papers produced by Sylvie Glaisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Glaisner. The network helps show where Sylvie Glaisner may publish in the future.
Co-authorship network of co-authors of Sylvie Glaisner
This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Glaisner. A scholar is included among the top collaborators of Sylvie Glaisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Glaisner. Sylvie Glaisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 68 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 95 | |
| 9 | 16 | |
| 10 | 16 | |
| 11 | 40 | |
| 12 | [Microbiological diagnosis of bacteremia from a catheter: a simple method? Results of a retrospective study]. | 2 |
| 13 | 2 | |
| 14 | 39 | |
| 15 | 1 | |
| 16 | 32 | |
| 17 | Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis? | 4 |
About Sylvie Glaisner
Sylvie Glaisner is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 17 papers that have together received 330 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (124 citations), Pathology and Forensic Medicine (188 citations) and Neurology (118 citations). Sylvie Glaisner has collaborated with scholars based in France, Australia and United States. Frequent co-authors include Hervé Dombret, L Degos, Sylvie Castaigné, Franck Morschhauser, Richard Delarue, Corinne Haïoun, Jean Gabarre, Ju Li, Olivier Fitoussi and Bertrand Coiffier. Their work appears in journals such as Blood, European Journal of Cancer and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.